Drugs Made In America Acquisition (DMII) Notes Payables (2024)
Drugs Made In America Acquisition (DMII) reported Notes Payables of $250100.0 for Q4 2024.
Drugs Made In America Acquisition (DMII) Notes Payables (2024) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Notes Payables data on file, last reported at $250100.0 in Q4 2024.
- Notes Payables for Q4 2024 came in at $250100.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $250100.0 (changed N/A YoY), and the FY2024 annual result was $250100.0, changed N/A from the prior year.
- Notes Payables held at $250100.0 in Q4 2024 per DMII's latest filing.
- Over five years, Notes Payables peaked at $250100.0 in Q4 2024 and troughed at $250100.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 250,100.00 |